The CCIC was established in December 2008 between 9 departments across KCL and UCL and was renewed in 2013 for an additional 5 years. This multi-institutional consortium is comprised of radiologists, surgeons, radiation oncologists, medical oncologists, biologists, chemists, physicists, engineers and mathematicians. The aim of the CCIC is to facilitate the development of new imaging agents and technologies and their application for the benefit of cancer patients. Cancer imaging-derived information, in combination with genomic and proteomic parameters, are being used for directing therapy, prediction of treatment-outcome and assessment of response to therapy.
Read more about our research.